Skip to main navigation Skip to search Skip to main content

Formulation for slow release of oral radiation-protection drugs

  • M. Abdulrazik*
  • , J. Shani
  • , S. Benita
  • , A. Samuni
  • , M. Donbrow
  • , A. Yerushalmi
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Cysteine and cysteamine, two effective radioprotectants in mammals, were compressed into tablets with a matrix composed of ethylcellulose and stearic acid at various proportions. The concentration of the unoxidized drug was monitored continuously for 8-16 h, as a parameter for the residual drug in the tablets with time, in vitro. Also, in vivo studies with tablets implanted into stomachs of rats, at various time intervals before their whole-body irradiation, were carried out. A correlation was obtained in the in vitro studies between the stearic acid/ethylcellulose ratio and the release rate of both radioprotectants, and the Higuchi's diffusional mechanism was demonstrated. In vivo, the best survival ratios were obtained when 8 h lapsed between implantation of the tablets in the stomachs and the irradiation. It is concluded that there is a distinct correlation between the in vitro release of the drugs and their in vivo efficacy as radioprotectants.

Original languageEnglish
Pages (from-to)53-54
Number of pages2
JournalInternational Journal of Nuclear Medicine and Biology
Volume11
Issue number1
DOIs
StatePublished - 1984

Fingerprint

Dive into the research topics of 'Formulation for slow release of oral radiation-protection drugs'. Together they form a unique fingerprint.

Cite this